Clinical Trial Update: Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating chemotherapy with or without radiation in low and intermediate risk Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Baylor College of Medicine | Conditions: Hodgkin Disease | Phase 2 | Status: COMPLETED